Chlorhexidine Gluconate (CHG) Wipes Market Trends

Growth Drivers

• Growing incidences of healthcare-related infection: Risk of infection during hospital stays or surgical interventions drives demand in the chlorhexidine gluconate wipes market. The rate of prevalence of these cases is concerning the authorities of such healthcare institutions such as hospitals and clinics as they increase medical expenditures. According to the National Healthcare Safety Network report, published in January 2024, the surgical site infection (SSI) standardized infection ratio (SIR) increased by 4% in the U.S. in 2022. The report further stated that SSI causes 20% of HAIs, increasing the annual hospitalization cost and reaching USD 3.3 billion. This is further pushing them to invest more in such disinfectant products.
• Rising demand for surgical disinfection: The growing need for surgical sterilization and disinfection in the healthcare setting is remarkably contributing to the chlorhexidine gluconate (CHG) wipes market enlargement. Diversified usage of these wipes for patient skin, surgical instruments, and OT beds is creating varied channels of application for this sector. This inspires manufacturers to bring innovation to their production and accessibility to their distribution. The use of these products can significantly reduce the prolonged treatments, caused by SSIs benefiting both patients and healthcare institutions. This sector is further influenced by improving and strengthening global surgery outcomes, ensuring equitable and sustainable surgical care.

Challenges

• Arising questions about health impact: Recently registered cases of skin irritation and allergic reaction due to using CHG-based products can limit the widespread of the chlorhexidine gluconate wipes market. The adverse effects may further impact consumer trust on the product’s effectiveness, hindering optimum and future adoption. This also creates an uncertainty of being replaced by new safer alternatives introduced in the healthcare industry. In addition, strict regulatory frameworks may restrict the usage of the wipes in several sectors, restricting market reach.  
• High production cost and pricing: The required initial cost of production in the chlorhexidine gluconate wipes market may become expensive for many manufacturers. This restricts maximum participation from companies with limited budgets. Additionally, the affordability issues among low-income and non-hospital healthcare settings can refrain from adopting these products. This makes it difficult for suppliers and manufacturers to gain profitable revenue from the market, diluting their interest in future investments and participation.